Zainab Shahid

Optometry
2626 N Belt Line Rd
Irving, TX 75062

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic Challenges.

Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic Challenges.

Journal: Transplantation and cellular therapy
Published: April 15, 2026

Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic Challenges.

Tuberculosis After Allogeneic Hematopoietic Cell Transplant: A 15-Year Case Series Highlighting Diagnostic Challenges.

Journal: Transplantation and cellular therapy
Published: April 15, 2026

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Journal: Blood advances
Published: January 07, 2026

Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell Therapy.

Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell Therapy.

Journal: Blood advances
Published: January 07, 2026

Respiratory Syncytial Virus After CAR T-cell therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort.

Respiratory Syncytial Virus After CAR T-cell therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 03, 2025

Respiratory Syncytial Virus After Chimeric Antigen Receptor T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort.

Respiratory Syncytial Virus After Chimeric Antigen Receptor T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 03, 2025

Vaccination should not be forgotten in patients receiving immunoglobulin replacement therapy.

Vaccination should not be forgotten in patients receiving immunoglobulin replacement therapy.

Journal: Blood advances
Published: August 20, 2025

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Journal: Blood
Published: August 20, 2025

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Journal: Blood
Published: August 20, 2025

Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell Therapy.

Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell Therapy.

Journal: Transplantation and cellular therapy
Published: July 15, 2025

Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma.

Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma.

Journal: Blood cancer journal
Published: June 21, 2025

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Journal: Blood cancer journal
Published: March 13, 2025
Showing 1-12 of 56

Last Updated: 09/26/2026